Alvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreement includes exclusive US commercialization rights.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/utwf1aO
via IFTTT
No comments:
Post a Comment